ENT Diagnostic Devices Market Projected to be Resilient During 2018 to 2028
The global ENT diagnostic devices market analysis is based on the market study in key regions including North America, Latin America, Europe, CIS & Russia, APEJ, Japan and MEA.
[UKPRwire, Mon Aug 05 2019] The purpose of this comprehensive forecast report presented by Fact.MR is to elaborate the various market projections impacting the global ENT diagnostic devices market during the period through 2018-2028. This assessment delivers high-end statistics concerning market size, growth in trends and revenue share (US& Mn) linked to different geographies and segmentation types. Readers can acquire precise insights about market growth trends along with upcoming opportunities that are expected to reshape the overall structure of the ENT diagnostic devices market during the forecast period.
Request for a Free Sample Report of Concerned Market - https://www.factmr.com/connectus/sample?flag=S&rep_id=2468
The ENT diagnostic devices market remains moderately consolidated among top 5 players who hold over half the market share. Top 5 players in the ENT diagnostic devices market are Medtronic Plc, Fujifilm Corporation, Smith and Nephew Plc., Stryker Corporation and Natus Medical Incorporated. Mergers and acquisitions are the prominent growth strategies adopted by these players. In addition, R&D collaborations are also prominent to lower the prices of ENT diagnostic devices. The ENT diagnostic devices market is also witnessing the emergence of local start-ups who are introducing low-priced devices. Owing to the successful penetration of these devices, the start-ups and small players have increased manufacturing capacities as well as regional market presence. Increasing revenues of these companies are challenging the hegemony of leading players in the ENT diagnostic devices market. As the medtech industry has shifted from marketing model to a care delivery model, greater strides are underway in the field of the medical diagnostic technology landscape. In a bid to introduce improved diagnosis, the ENT diagnostic devices marketplace has witnessed the introduction of multiple breakthrough innovations. Telemedicine is a phenomenon in the otolaryngology which brings medical care to patients. Although, otolaryngology has witnessed slower adoption of telemedicine, advances in audiograms, diagnostic imaging and endoscopy have increased use of telemedicine approach.
Further, to bridge the gap between patient and point of care, ENT diagnostic devices market is witnessing the introduction of smart devices. For instance, after Cupris Health’s introduction of smartphone otoscope in January 2018, in May 2018, hearX Group introduced the world’s first clinically validated smartphone audiometry solution hearTest.
Problems associated with ear, nose and throat are among the most common factors responsible for hospital visits, particularly among the pediatric population. The ageing population has further increased the number of hospital visits for ENT problems across the globe. According to a survey study by Massachusetts Eye and Ear Infirmary, prevalence of tinnitus was found to be between 8 to 25.3% of the population of the United States. Between 10 to 30% of the population in the United States and Europe is affected by Sinusitis. Advances in the accessibility of healthcare facilities and favorable reimbursement policies for ENT procedures have increased the number of ENT surgeries performed for the treatment of ENT related diseases. Prevalence of ENT disorders and rising penetration of ENT surgeries are expected to increase the importance of ENT diagnostic devices in the future.
High Cost of the ENT Diagnostic Devices to Hamper Market Growth
Acquiring an ENT diagnostic device involves an initial capital investment of device purchase and set up, and further cost of repair and maintenance. The cost recovery depends on uncertain factors such as the number of procedures performed per day. Further, limited financial support in specific locations impedes the adoption of improved ENT diagnostic devices in the healthcare facilities. In addition, developing markets lack the awareness regarding the full potential of ENT diagnostic devices, thereby restraining the growth of the ENT diagnostic devises market. Also, inadequate healthcare infrastructure of these markets shows unreadiness for the adoption of advanced ENT devices owing to lack of knowledge and financial abilities. As diagnosis plays a crucial role in disease management, doctors remain heavily dependent on diagnostic testing. Particularly in the ENT field, observation of ear, nose and throat remains challenging owing to the physiology of organs. ENT diagnostic devices aid in the efficient management of ENT diseases.
Ask Industry Experts about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=2468
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Suite 400, Rockville, MD 20852